The second point, the relationship between MUTYH monoallelic variants and cancer predisposition, is much more controversial: three different studies so far concluded with a slightly increased risk of CRC in monoallelic carriers of MUTYH PVs [3, 4, 5] though other researchers do not agree [7, 31]. Here, MUTYH is linked to cancer.